Ernexa Therapeutics Inc.

ERNAW

—

Advanced chart & tools →

Ernexa Therapeutics Inc.ERNAW

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.24

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$582,000

Net income

$-14.08M

Net margin

-2419.9%

Gross margin

83.5%

Dividends & financials

Ernexa Therapeutics Inc. (ERNAW) reported revenue of $582,000 and net income of $-14.08M, or $-2.24 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.